Alnylam Pharmaceuticals, Inc. Share Price
Equities
ALNY
US02043Q1076
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.4 USD | -0.33% | -3.21% | -22.99% |
Sales 2024 * | 187.19Cr 16TCr | Sales 2025 * | 225.94Cr 19TCr | Capitalization | 1.86TCr 1,55500Cr |
---|---|---|---|---|---|
Net income 2024 * | -45Cr -3.76TCr | Net income 2025 * | -26Cr -2.14TCr | EV / Sales 2024 * | 9.29 x |
Net cash position 2024 * | 126.24Cr 11TCr | Net cash position 2025 * | 47Cr 3.96TCr | EV / Sales 2025 * | 8.04 x |
P/E ratio 2024 * |
-41.7
x | P/E ratio 2025 * |
-79.2
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.59% |
Latest transcript on Alnylam Pharmaceuticals, Inc.
1 day | -0.33% | ||
1 week | -3.21% | ||
Current month | +2.40% | ||
1 month | -0.20% | ||
3 months | -0.02% | ||
6 months | -13.83% | ||
Current year | -22.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 19/16/19 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 56 | 13/19/13 |
Piyush Sharma
CMP | Compliance Officer | - | 21/22/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 18/15/18 |
Charles Sigal
BRD | Director/Board Member | 72 | 22/22/22 |
Margaret Hamburg
BRD | Director/Board Member | 68 | 10/19/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.08% | 1 M€ | -2.17% | - | |
4.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 147.4 | -0.33% | 536,143 |
14/24/14 | 147.9 | -1.33% | 604,966 |
13/24/13 | 149.9 | -0.39% | 512,792 |
10/24/10 | 150.5 | -0.59% | 322,795 |
09/24/09 | 151.4 | -0.60% | 329,246 |
Delayed Quote Nasdaq, May 16, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.99% | 1.87TCr | |
+29.77% | 4.92TCr | |
+1.00% | 4.21TCr | |
+50.47% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.68% | 2.61TCr | |
+8.22% | 1.33TCr | |
+32.41% | 1.23TCr | |
-1.62% | 1.2TCr | |
+24.01% | 1.2TCr |
- Stock Market
- Equities
- ALNY Stock